| Name | Title | Contact Details |
|---|
At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 65-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what`s possible to ensure every breath is taken to its fullest. We accomplish this through our values: One Voice, Patient Purpose, Promises Kept and Expansive Innovation. The company`s origin began in the 1950s with the invention of the first mechanical ventilator and has since brought together well-known brands with proven track-records of pioneering and advancing respiratory diagnostics, ventilation, and anesthesia delivery and monitoring. Formed in 2016, the unified Vyaire established the world`s largest consortium of experts and industry leaders solely focused on the breathing continuum for customers and patients across the globe. Vyaire`s passionate, dedicated global workforce of 4,000 consists of experienced breathing specialists that are inspired and empowered to elevate the quality of each inhale and each exhale. Vyaire acknowledges and celebrates the individual backgrounds, perspectives, and voices of our team members to best serve the diverse needs of patients and healthcare providers. Bring your unique talents, commitment, and career aspirations to our global team of dedicated professionals. Headquartered in suburban Chicago, Vyaire is recognized, trusted and preferred by specialists throughout the respiratory community worldwide.
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.
The Female Health Company is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OBP Medical Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
High Technology is a Walpole, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.